Sponsored by:
References (Cont’d) 6. Taban M, Boyer DS, Thomas EL. Chronic Central Serous Chorioretinopathy: Photodynamic Therapy. Am J Ophthalmol 2004; 137: 1073-1080. 7. Carvalho-Recchia CA, Yannuzzi LA, Negrao S, Spaide RF, Freund KB, Rodriguez-Coleman H, Lenharo M, lida T. Corticosteroids and Central Serous Chorioretinopathy. Ophthalmology 2002; 109: 1834-1837. 8. Wynn PA. Idiopathic central serous chorioretinopathy-a
References 1. Pérez-Carro G, Miranda-Rollón M, Junceda-Moreno C, Alvarez-Sánchez M, Junceda-Moreno J. Congenital Retinal Macrovessels: A Discovery by Chance. Arch Soc Esp Oftalmol 2008; 83: 273-276. 2. Wang M, Munch IC, Hasler PW, Prunte C, Larsen M. Central serous chorioretinopathy. Acta Ophthalmol 2008; 86: 126-145 3. Fujimoto H et al. Morphologic Changes in Acute
Acknowledgments Sanjeev Nath Jeremy Whitney Kyle Bensinger
Jerome Sherman, OD, FAAO Jerome Sherman, O.D., is perhaps optometry's most prolific writer, publishing over 650 clinical articles, research manuscripts, book chapters and two CDs. He is senior author of three books that were published in 2007, and has delivered over three thousand lectures both nationally and internationally. He has served as a contributing
The following is a list of links to the companies and contributors of:
Comments and Conclusions (Cont’d) • Acute CSC has been significantly associated with stress and Type A personality. In a study of 33 patients with acute CSC, 91% had experienced a “very disturbing” psychological event prior to the disturbed vision (such is the case in our first patient) and were “tension ridden”.8,9 • It has been
Comments and Conclusions • CSC is one of the 10 most common diseases of the posterior segment of the eye and a frequent cause of mild to moderate visual impairment.² • Optical coherence tomography (OCT) has provided a better understanding of the mechanism in CSC, especially the abnormalities of the RPE layer.³,⁴ • OCT
Heidelberg Engineering SPECTRALIS® OCT Date Comparisons OD October 2007 December 2007 January 2008
Heidelberg Engineering SPECTRALIS® OCT and Fluorescein Angiography Images OD January 2008 An OCT section through the macula three months after the initial visit.
Heidelberg Engineering SPECTRALIS® OCT and Fluorescein Angiography Images OD December 2007 An OCT section through the macula two months after the initial visit.
